Prostate cancer fixated prognosis

I like to read prognosis for the future and here I planned to have a pleasure to go through a prognosis for 2013: Cleveland Clinic Names Top 10 Medical Innovations for 2013.

After reading the first question was: why this prognosis is interested in only drugs against prostate cancer? But O key, let's take only these drugs:

In the past two years, five new drugs have been approved for advanced prostate cancer: sipuleucel-T, denosumab, abiraterone, cabazitaxel, and enzalutamide. A sixth, radium-223 dichloride, is expected to be approved later this year.

Significant progress has been made in treating advanced prostate cancer, not only by greatly increasing patient survival, but also by halting the progress of this disease.

Many in the prostate cancer research community now believe that these drugs, and others coming from the prostate cancer therapeutic pipeline, will one day help make advanced prostate cancer a chronic disease that’s successfully managed with a routine of daily medication, lifestyle modification, and regular checkups.

Well, I do not understand the message: what should be considered as innovation? Radium-223 dichloride? Or 5 new drugs that already have been approved? I am a little disappointed with this prognosis/prediction. Bad job, not professionally done!